Cognitive Impairment in CKD: Keep Vascular Disease in Mind: Commentary for Kidney International on ‘Cognitive impairment in chronic kidney disease: Prevalence, severity and association with HbA1c and fibrinogen’

Cognitive impairment is a major cause of morbidity in people with chronic kidney disease (CKD) and is associated with lower quality of life, more difficulty adhering to medications, and worse survival. Prior data suggest a relationship between vascular disease and cognitive impairment in individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Drew, David A, Weiner, Daniel E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097111/
https://www.ncbi.nlm.nih.gov/pubmed/24583984
http://dx.doi.org/10.1038/ki.2013.437
_version_ 1782326191806480384
author Drew, David A
Weiner, Daniel E
author_facet Drew, David A
Weiner, Daniel E
author_sort Drew, David A
collection PubMed
description Cognitive impairment is a major cause of morbidity in people with chronic kidney disease (CKD) and is associated with lower quality of life, more difficulty adhering to medications, and worse survival. Prior data suggest a relationship between vascular disease and cognitive impairment in individuals with CKD, although overall risk factors remain poorly understood. Critically, clinicians should be aware of the high rates of cognitive impairment that occur in all stages of CKD, which, although sometimes subtle, may impact comprehension and decision making in these individuals and may herald future, more debilitating impairment.
format Online
Article
Text
id pubmed-4097111
institution National Center for Biotechnology Information
language English
publishDate 2014
record_format MEDLINE/PubMed
spelling pubmed-40971112014-09-01 Cognitive Impairment in CKD: Keep Vascular Disease in Mind: Commentary for Kidney International on ‘Cognitive impairment in chronic kidney disease: Prevalence, severity and association with HbA1c and fibrinogen’ Drew, David A Weiner, Daniel E Kidney Int Article Cognitive impairment is a major cause of morbidity in people with chronic kidney disease (CKD) and is associated with lower quality of life, more difficulty adhering to medications, and worse survival. Prior data suggest a relationship between vascular disease and cognitive impairment in individuals with CKD, although overall risk factors remain poorly understood. Critically, clinicians should be aware of the high rates of cognitive impairment that occur in all stages of CKD, which, although sometimes subtle, may impact comprehension and decision making in these individuals and may herald future, more debilitating impairment. 2014-03 /pmc/articles/PMC4097111/ /pubmed/24583984 http://dx.doi.org/10.1038/ki.2013.437 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Drew, David A
Weiner, Daniel E
Cognitive Impairment in CKD: Keep Vascular Disease in Mind: Commentary for Kidney International on ‘Cognitive impairment in chronic kidney disease: Prevalence, severity and association with HbA1c and fibrinogen’
title Cognitive Impairment in CKD: Keep Vascular Disease in Mind: Commentary for Kidney International on ‘Cognitive impairment in chronic kidney disease: Prevalence, severity and association with HbA1c and fibrinogen’
title_full Cognitive Impairment in CKD: Keep Vascular Disease in Mind: Commentary for Kidney International on ‘Cognitive impairment in chronic kidney disease: Prevalence, severity and association with HbA1c and fibrinogen’
title_fullStr Cognitive Impairment in CKD: Keep Vascular Disease in Mind: Commentary for Kidney International on ‘Cognitive impairment in chronic kidney disease: Prevalence, severity and association with HbA1c and fibrinogen’
title_full_unstemmed Cognitive Impairment in CKD: Keep Vascular Disease in Mind: Commentary for Kidney International on ‘Cognitive impairment in chronic kidney disease: Prevalence, severity and association with HbA1c and fibrinogen’
title_short Cognitive Impairment in CKD: Keep Vascular Disease in Mind: Commentary for Kidney International on ‘Cognitive impairment in chronic kidney disease: Prevalence, severity and association with HbA1c and fibrinogen’
title_sort cognitive impairment in ckd: keep vascular disease in mind: commentary for kidney international on ‘cognitive impairment in chronic kidney disease: prevalence, severity and association with hba1c and fibrinogen’
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097111/
https://www.ncbi.nlm.nih.gov/pubmed/24583984
http://dx.doi.org/10.1038/ki.2013.437
work_keys_str_mv AT drewdavida cognitiveimpairmentinckdkeepvasculardiseaseinmindcommentaryforkidneyinternationaloncognitiveimpairmentinchronickidneydiseaseprevalenceseverityandassociationwithhba1candfibrinogen
AT weinerdaniele cognitiveimpairmentinckdkeepvasculardiseaseinmindcommentaryforkidneyinternationaloncognitiveimpairmentinchronickidneydiseaseprevalenceseverityandassociationwithhba1candfibrinogen

Ejemplares similares